Guicheng Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Guicheng Zhao has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Dingming Li
Department of Andrology/Sichuan Human Sperm Bank Key Laboratory of Obstetric, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education West China Second University Hospital Sichuan University Chengdu China
2 shared publications- Hengzhou Bai
Andrology Department, West China Second University Hospital, Sichuan University
2 shared publications Juntao Yue
Andrology Department, West China Second University Hospital, Sichuan University
2 shared publicationsKun Tian
Andrology Department, West China Second University Hospital, Sichuan University
2 shared publications- Xiaohui Jiang
Reproductive Andrology and Sichuan Human Sperm Bank, Key Laboratory of Obstetric, Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University , Chengdu, Sichuan
2 shared publications - Yi Zheng
Andrology Department, West China Second University Hospital, Sichuan University
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 15 (1) , 26
Shorter interval between consecutive testicular sperm aspirations and clinical pregnancy after intracytoplasmic sperm injection in obstructive azoospermia: a retrospective cohort study
The impact of the interval between consecutive testicular sperm aspiration (TESA) procedures on pregnancy outcomes of intracytoplasmic sperm injection (ICSI) in patients with obstructive azoospermia (OA) remains controversial. This study aimed to evaluate the impact of the interval between consecutive TESA procedures on clinical pregnancy outcomes of ICSI in patients with OA. We retrospectively analyzed 751 men with OA who underwent two consecutive TESA procedures at Reproduction Medical Center of West China Second University Hospital, Sichuan University between January 2015 and March 2023. The index outcome was clinical pregnancy in the ICSI cycle paired with the second (retrieval-day) TESA. Patients were divided into pregnancy and non-pregnancy groups. Group comparisons included TESA interval, patient age, hormone levels, and embryology outcomes. A total of 751 patients with OA were included, with an overall pregnancy rate of 51.7% (388/751). The short-interval group showed a higher pregnancy rate in one contrast (≤3 vs. >3 months, 56.0% vs. 47.9%, P=0.03), whereas the four-group comparison and the pregnant vs. non-pregnant mean interval comparison were not statistically significant. Exploratory stratified analyses were consistent with a short-interval advantage. Adjusted analyses yielded similar point estimates but results were not fully consistent across specifications. Same-side vs. opposite-side procedures had no significant impact on outcomes (50.8% vs. 54.9%, P=0.38). In this retrospective cohort of men with OA undergoing ICSI, repeating TESA within 3 months did not compromise clinical pregnancy outcomes. Overall differences across interval definitions were small and inconsistent, supporting the practicality of proceeding to an ICSI cycle shortly after an outpatient TESA when clinically appropriate. Prospective studies are warranted.
- 1 January 2026
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 15 (1) , 26
Open AccessShorter interval between consecutive testicular sperm aspirations and clinical pregnancy after intracytoplasmic sperm injection in obstructive azoospermia: a retrospective cohort study
The impact of the interval between consecutive testicular sperm aspiration (TESA) procedures on pregnancy outcomes of intracytoplasmic sperm injection (ICSI) in patients with obstructive azoospermia (OA) remains controversial. This study aimed to evaluate the impact of the interval between consecutive TESA procedures on clinical pregnancy outcomes of ICSI in patients with OA. We retrospectively analyzed 751 men with OA who underwent two consecutive TESA procedures at Reproduction Medical Center of West China Second University Hospital, Sichuan University between January 2015 and March 2023. The index outcome was clinical pregnancy in the ICSI cycle paired with the second (retrieval-day) TESA. Patients were divided into pregnancy and non-pregnancy groups. Group comparisons included TESA interval, patient age, hormone levels, and embryology outcomes. A total of 751 patients with OA were included, with an overall pregnancy rate of 51.7% (388/751). The short-interval group showed a higher pregnancy rate in one contrast (≤3 vs. >3 months, 56.0% vs. 47.9%, P=0.03), whereas the four-group comparison and the pregnant vs. non-pregnant mean interval comparison were not statistically significant. Exploratory stratified analyses were consistent with a short-interval advantage. Adjusted analyses yielded similar point estimates but results were not fully consistent across specifications. Same-side vs. opposite-side procedures had no significant impact on outcomes (50.8% vs. 54.9%, P=0.38). In this retrospective cohort of men with OA undergoing ICSI, repeating TESA within 3 months did not compromise clinical pregnancy outcomes. Overall differences across interval definitions were small and inconsistent, supporting the practicality of proceeding to an ICSI cycle shortly after an outpatient TESA when clinically appropriate. Prospective studies are warranted.
- 19 October 2024
- Published by MyJove Corporation
- No. 212,p. e67148
JoVE Video Dataset
No-scalpel vasectomy (NSV) is a commonly used contraceptive method for males. In previous applications of this surgical method, issues such as knot detachment and postoperative recanalization resulted in a reduced contraceptive success rate after vasectomy. This new technique innovatively modifies the ligation procedure during NSV to address knot detachment and postoperative recanalization. Two ligations of the testicular end of the vas deferens and one ligation of the abdominal end are completed before transection of the vas deferens. A fourth ligation of the abdominal end is performed using the suture tails of the third ligature of the testicular end after transection of the vas deferens. The fifth ligation of the abdominal end is performed using the suture tails of the first ligature of the testicular end. These modifications strengthen the ligations and reduce the postoperative recanalization rate. Additionally, the two stumps are gathered together, creating better conditions for a possible vasovasostomy in the future, thereby achieving overall better outcomes with vasectomy.
- 19 October 2024
- Published by MyJove Corporation
- No. 212,p. e67148
JoVE Video Dataset
No-scalpel vasectomy (NSV) is a commonly used contraceptive method for males. In previous applications of this surgical method, issues such as knot detachment and postoperative recanalization resulted in a reduced contraceptive success rate after vasectomy. This new technique innovatively modifies the ligation procedure during NSV to address knot detachment and postoperative recanalization. Two ligations of the testicular end of the vas deferens and one ligation of the abdominal end are completed before transection of the vas deferens. A fourth ligation of the abdominal end is performed using the suture tails of the third ligature of the testicular end after transection of the vas deferens. The fifth ligation of the abdominal end is performed using the suture tails of the first ligature of the testicular end. These modifications strengthen the ligations and reduce the postoperative recanalization rate. Additionally, the two stumps are gathered together, creating better conditions for a possible vasovasostomy in the future, thereby achieving overall better outcomes with vasectomy.
- 18 October 2024
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 212,p. e67148
Optimizing the Modified No-Scalpel Vasectomy Technique
No-scalpel vasectomy (NSV) is a commonly used contraceptive method for males. In previous applications of this surgical method, issues such as knot detachment and postoperative recanalization resulted in a reduced contraceptive success rate after vasectomy. This new technique innovatively modifies the ligation procedure during NSV to address knot detachment and postoperative recanalization. Two ligations of the testicular end of the vas deferens and one ligation of the abdominal end are completed before transection of the vas deferens. A fourth ligation of the abdominal end is performed using the suture tails of the third ligature of the testicular end after transection of the vas deferens. The fifth ligation of the abdominal end is performed using the suture tails of the first ligature of the testicular end. These modifications strengthen the ligations and reduce the postoperative recanalization rate. Additionally, the two stumps are gathered together, creating better conditions for a possible vasovasostomy in the future, thereby achieving overall better outcomes with vasectomy.
- 18 October 2024
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 212,p. e67148
Optimizing the Modified No-Scalpel Vasectomy Technique
No-scalpel vasectomy (NSV) is a commonly used contraceptive method for males. In previous applications of this surgical method, issues such as knot detachment and postoperative recanalization resulted in a reduced contraceptive success rate after vasectomy. This new technique innovatively modifies the ligation procedure during NSV to address knot detachment and postoperative recanalization. Two ligations of the testicular end of the vas deferens and one ligation of the abdominal end are completed before transection of the vas deferens. A fourth ligation of the abdominal end is performed using the suture tails of the third ligature of the testicular end after transection of the vas deferens. The fifth ligation of the abdominal end is performed using the suture tails of the first ligature of the testicular end. These modifications strengthen the ligations and reduce the postoperative recanalization rate. Additionally, the two stumps are gathered together, creating better conditions for a possible vasovasostomy in the future, thereby achieving overall better outcomes with vasectomy.
- Open Access
- 23 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (8) , e37201
Case report: remedial microdissection testicular sperm extraction after onco-microdissection testicular sperm extraction failure
Background: Testicular cancer (TC) mostly occurs in men aged 14 to 44. Studies have shown that TC seriously damages male fertility, and 6% to 24% of patients with TC were even found to suffer from azoospermia when they are diagnosed. At present, some studies have pointed out that onco-microdissection testicular sperm extraction (mTESE) can extract sperm from tumor testicles. However, there are almost no reports on remedial measures after onco-mTESE failure. Given the valuable opportunity for fertility preservation in patients with TC and azoospermia, it is necessary to provide effective remedial methods for patients with failed onco-mTESE. Methods: Two young men, who were diagnosed with TC and also found to have azoospermia, tried onco-mTESE while undergoing radical orchiectomy for fertility preservation. However, sperm extraction failed in both patients. Subsequently, the isolated testicular tissue of the patient in case 1 suffered from TC again, and the patient in case 2 was scheduled to receive multiple cycles of gonadotoxic chemotherapy. Because both had a plan to have a birth in the future, we performed remedial mTESE. Results: Sperm was successfully extracted from both patients. The patient recovered well, without complications. The patient couple in case 1 underwent 1 intracytoplasmic sperm injection (ICSI) cycle but did not achieve clinical pregnancy. Conclusions: There is still an opportunity to extract sperm successfully using onco-mTESE, despite the difficulty of fertility preservation in TC patients with azoospermia. If sperm extraction from the tumor testis fails, implementing remedial mTESE as early as possible would likely preserve the last chance of fertility for these patients.
- 23 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (8) , e37201
Open AccessCase report: remedial microdissection testicular sperm extraction after onco-microdissection testicular sperm extraction failure
Background: Testicular cancer (TC) mostly occurs in men aged 14 to 44. Studies have shown that TC seriously damages male fertility, and 6% to 24% of patients with TC were even found to suffer from azoospermia when they are diagnosed. At present, some studies have pointed out that onco-microdissection testicular sperm extraction (mTESE) can extract sperm from tumor testicles. However, there are almost no reports on remedial measures after onco-mTESE failure. Given the valuable opportunity for fertility preservation in patients with TC and azoospermia, it is necessary to provide effective remedial methods for patients with failed onco-mTESE. Methods: Two young men, who were diagnosed with TC and also found to have azoospermia, tried onco-mTESE while undergoing radical orchiectomy for fertility preservation. However, sperm extraction failed in both patients. Subsequently, the isolated testicular tissue of the patient in case 1 suffered from TC again, and the patient in case 2 was scheduled to receive multiple cycles of gonadotoxic chemotherapy. Because both had a plan to have a birth in the future, we performed remedial mTESE. Results: Sperm was successfully extracted from both patients. The patient recovered well, without complications. The patient couple in case 1 underwent 1 intracytoplasmic sperm injection (ICSI) cycle but did not achieve clinical pregnancy. Conclusions: There is still an opportunity to extract sperm successfully using onco-mTESE, despite the difficulty of fertility preservation in TC patients with azoospermia. If sperm extraction from the tumor testis fails, implementing remedial mTESE as early as possible would likely preserve the last chance of fertility for these patients.